|
| |
nexmed patents Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - NexMed
NexMed Patents:. US Patent No. Title. 7105571, Prostaglandin compositions and methods of treatment for male erectile dysfunction ...
http://www.bioportfolio.com/biocorporate/7520-NexMed.html...
|
{1} Announces Patent Allowance For Room Temperature Stable Alprox ...
Dr. Y. Joseph Mo, President and C.E.O. of NexMed, commented, "We are very excited by this patent allowance since it covers the next generation of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1790542...
|
BioPortfolio - NexMed - Profile
Pharma Live: Oct 13 2008 3:31PM Matching: nexmed. NexMed Patents:. • 7105571- Prostaglandin compositions and methods of treatment for male erectile ...
http://www.bioportfolio.com/biocorporate/7520-NexMed.pdf...
|
NexMed Announces $3.5 Million Milestone Payment: Financial News ...
Pursuant to the terms of the agreement, NexMed, having paid the issuance fee for the allowed U.S. patent, is now entitled to receive a $2 million milestone ...
http://biz.yahoo.com/bw/081027/20081027005262.html?.v=1...
|
News: NexMed Receives $3.5M from Novartis Related to Nail Fungal ...
27 Oct 2008 ... NexMed reports that due to the extensive delay in the review and processing of the patent application, the U.S. PTO added 756 days to the ...
http://www.genengnews.com/news/bnitem.aspx?name=44270407&nc=...
|
Summary of NEXMED INC - Yahoo! Finance
(3) with patents expiring or expired and (4) with proven market track records ... 2006 through June 2007 and has served as a Director of NexMed since 2002.
...
http://biz.yahoo.com/e/081110/nexm10-q.html...
|
NexMed Receives $3.5M from Novartis Related to Nail Fungal ...
Today’s milestone payments cover $2 million due to allowance of the patent application entitled “Antifungal Nail Coat and Method of Use,” for which NexMed
...
http://www.genengnews.com/news/bnitem_print.aspx?name=442704...
|
{1} Initiates 400 Patient Femprox Study Overseas - News, Search ...
In April 2004, NexMed announced that it had received a Notice of Allowance for its patent application entitled, "Compositions and Methods for Amelioration ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1660942...
|
BioPortfolio - Female Sexual Dysfunction
Female Sexual Dysfunction Patents:. USPTO Logo. US Patent No. Title ... NexMed is an innovative drug developer that is leveraging its proprietary NexACT® ...
http://www.bioportfolio.com/indepth/Female_Sexual_Dysfunctio...
|
NexMed Announces $3.5 Million Milestone Payment - News, Search ...
EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of ... The patent, when issued, will cover NM100060, a topical application of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=114535...
|
|
